-transparent.png){kind=logo}
Recent studies have demonstrated that the biovailability of gitoxin could be increased to 100%. Favorable pharmacokinetic parameters for this glycoside have also been found in humans. The present paper deals with the comparative hemodynamic effect of digoxin and gitoxin on nine patients suffering from heart failure. The study was conducted in a coronary care unit with continuous hemodynamic monitoring. After intravenous administration of 1 mg digoxin or gitoxin, only gitoxin was observed to have an inotropic effect leading to significant improvement of the low cardiac output in these patients.
Related Publications
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
May 1977,
American heart journal,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
October 1969,
Annals of the New York Academy of Sciences,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
January 1977,
Acta cardiologica,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
November 1991,
JAMA,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
July 1996,
Journal of the American College of Cardiology,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
February 1997,
Journal of the American College of Cardiology,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
January 1981,
Journal of clinical pharmacology,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
July 2000,
American family physician,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
January 1989,
European journal of clinical pharmacology,
J Col, and
W Wijns, and
L Brasseur, and
M Lesne
July 1986,
Japanese circulation journal,
